Andrew R. Nager
Pfizer (United States)(US)Université Bourgogne Franche-Comté(FR)
Publications by Year
Research Areas
Genetic and Kidney Cyst Diseases, Cellular transport and secretion, CAR-T cell therapy research, Peptidase Inhibition and Analysis, Protein Structure and Dynamics
Most-Cited Works
- → An Actin Network Dispatches Ciliary GPCRs into Extracellular Vesicles to Modulate Signaling(2016)384 cited
- → BBSome trains remove activated GPCRs from cilia by enabling passage through the transition zone(2018)268 cited
- → Structures of Asymmetric ClpX Hexamers Reveal Nucleotide-Dependent Motions in a AAA+ Protein-Unfolding Machine(2009)261 cited
- → The Intraflagellar Transport Protein IFT27 Promotes BBSome Exit from Cilia through the GTPase ARL6/BBS3(2014)211 cited
- → The proteasome 19S cap and its ubiquitin receptors provide a versatile recognition platform for substrates(2020)163 cited
- → Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab(2018)143 cited
- → Nucleotide Binding and Conformational Switching in the Hexameric Ring of a AAA+ Machine(2013)109 cited
- → Ubiquitin chains earmark GPCRs for BBSome-mediated removal from cilia(2020)94 cited
- → Structural basis for membrane targeting of the BBSome by ARL6(2014)91 cited
- → Stepwise Unfolding of a β Barrel Protein by the AAA+ ClpXP Protease(2011)74 cited